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Abstract
Background: Smith Lemli Opitz syndrome (SLOS; OMIM #270400) is an autosomal recessive metabolic disorder
caused by mutations in the DHCR7 gene. SLOS is characterized by a plethora of abnormalities involving mainly the
brain and the genitalia but also the cardiac, skeletal and gastroenteric system, typical dysmorphic facial features,
and variable degrees of developmental delay and intellectual disability (ID). SLOS has a broad phenotypic spectrum,
ranging from multiple congenital malformation syndrome, to mild developmental delay and minor malformations.
A large number of mutations have been described in the DHCR7 gene, with few common mutations accounting
for the majority of mutated alleles found in patients and a large number of very rare or even private variants. Due
to the wide variety of clinical presentations, diagnosis can be difficult, especially in the milder forms of the disorder.
Furthermore, establishing a molecular diagnosis can be complicated by finding variants of unknown clinical
significance in such cases.
Case presentation: We report a case of SLOS at the mild end of the clinical spectrum, presenting with bilateral
pelvis ectasia, mild dysmorphic features and mild intellectual disability. The case is compound heterozygous for a
known pathogenic mutation (c.724C > T, p.Arg242Cys) and a mutation that has only been reported once in a
Portuguese patient (c.521 T > C, p.Phe174Ser) whose pathogenicity has not been yet assessed. We compared the
two patients carrying the p.Phe174Ser variant and concluded that this variant is associated with mild forms of SLOS.
Conclusion: We report a patient with a mild case of SLOS, highlighting the importance of recognizing subtle
anomalies of the genitourinary system, associated with mild dysmorphic features and mild intellectual disability in
establishing the diagnosis of mild forms of SLOS. With this report, we confirm the pathogenicity of the p.Phe174Ser
variant and we also provide evidence of its association with mild forms of SLOS. This finding further facilitates the
establishment of a genotype–phenotype correlation for SLOS. This helps in counselling for this disorder and in
predicting therapeutic responses.
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Background
Smith Lemli Opitz syndrome (SLOS; OMIM #270400) is
an autosomal recessive multiple congenital anomaly syn-
drome caused by mutations in the DHCR7 gene [1–3].
The prevalence of SLOS has been estimated to range be-
tween 1:15,000 and 1:60,000 in populations of European
origin [4, 5], with a carrier frequency that may be as high
as 2 % in certain populations [6], making it one of
the most commonly inherited metabolic defects in the
Caucasian population.
SLOS has a broad phenotypic spectrum ranging from
multiple congenital malformation syndrome to mild de-
velopmental delay and minor malformations [7]. Whilst
individuals with milder forms of SLOS may have only
subtle facial characteristics and mild to no ID, individ-
uals affected by the most severe forms of SLOS may
have life-threatening multiple congenital malformations
* Correspondence: donatella.milani@policlinico.mi.it
1Pediatric Highly Intensive Care Unit, Department of Pathophysiology and
Transplantation, Università degli Studi di Milano,Fondazione IRCCS Ca’
Granda Ospedale Maggiore Policlinico, Via Commenda 9, 20122 Milan, Italy
Full list of author information is available at the end of the article
© 2016 Tucci et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Tucci et al. BMC Medical Genetics  (2016) 17:22 
DOI 10.1186/s12881-016-0287-1
involving the brain, heart, lungs, and genitourinary
system. Structural anomalies of the brain and microcephaly
along with anomalies of the genitalia (namely hypospadia)
are commonly found in individuals with SLOS and help
guide the diagnosis. The classical facial appearance is char-
acterized by bitemporal narrowing, a short upturned nose
with anteverted nares, epicanthus, ptosis, retrognathia, and
low set ears. Y-shaped syndactyly of the second and third
toes and cleft palate are common but not universal find-
ings that help to guide the diagnosis [8].
The DHCR7 gene encodes 7-dehydrocholesterol re-
ductase, the ultimate enzyme of sterol biosynthesis
that converts 7-dehydrocholesterol to cholesterol [9].
Patients have elevated plasma concentrations of 7-de-
hydrocholesterol, and most also have low circulating levels
of cholesterol [4] The DHCR7 gene encodes a protein of
475 amino acid residues. The DHCR7 protein consists of
nine transmembrane (TM) domains and corresponding
cytoplasmic loops of which the fourth is thought to contain
the putative active site. To date, approximately 140 gene
mutations have been identified across the DHCR7 gene
(http://www.hgmd.cf.ac.uk/ac/index.php 19/08/2015). The
13 most frequent mutations account for approximately
two-thirds of all mutant alleles found in DHCR7, indi-
cating a large number of very rare or even private mu-
tations [10].
We report a case of SLOS at the mild end of the clin-
ical spectrum, who is compound heterozygous for a
known pathogenic mutation (c.724C > T, p.Arg242Cys)
and a mutation that has only been reported once in the
Portuguese population (c.521 T > C, p.Phe174Ser) [11].
Case presentation
The proband, a 7 year old boy, was the second child of
unrelated parents. His father was Italian, and his mother
was of Cuban ancestry. Both his parents and his older
sister were healthy. In the family history, a female cousin
of his mother was reported to be mildly intellectually
disabled. A male cousin of his father also had an ID.
During the pregnancy, a potential miscarriage was re-
ported. The foetal ultrasound scans at 12 and 20 weeks
of gestation reported normal growth and development.
He was delivered at term by vaginal delivery. He was
noted to be mildly microcephalic (occipitofrontal cir-
cumference [OFC] 33 cm, on the 0.4th centile), with a
birth weight of 2880 Kg (10th centile), a length of 49 cm
(10th centile), and an APGAR score of 9/10.
Postnatally, he demonstrated growth restriction with
height and weight consistently on or just below the 0.4th
centile, and a head circumference growing well below
the 0.4th centile. He was noted to be slightly dysmorphic
with bilateral ptosis, epicanthal folds, hypertelorism, a
broad nasal bridge with anteverted nares, and posteriorly
rotated ears. The hand and foot examination showed
proximally placed thumbs, bilateral single hand creases,
and partial bilateral 2–3 toe syndactyly (Fig. 1).
At 19 months of age, neuropsychiatric assessment re-
vealed global hypotonia and borderline psychomotor de-
velopment with a Griffith’s scale value of 93. At this
stage, a number of investigations were carried out in-
cluding cranial ultrasound, which was normal; electro-
cardiography, which was normal; and echocardiogram,
which demonstrated a patent foramen ovale, then spon-
taneously closed; pelvic and abdominal ultrasound scan,
which revealed bilateral pelvic ectasia more marked on
the left consistent with bifid pelvis on this side; spine
and hip X-ray, which were normal; and a metabolic
screen, including urinary mucopolysaccharides, urinary
oligosaccharides, and urinary organic acids, which were
all normal. First-line genetic analyses were carried out:
chromosome analysis by karyotype and array-CGH were
normal. Given the dysmorphic features, the short stature
and the cardiac defect, Noonan Syndrome was sus-
pected. Molecular analysis of PTPN11 and SOS1 did not
reveal any pathogenic mutation.
At the age of four years, neuropsychiatric assessment
confirmed mild psychomotor delay, with an intelligence
quotient (IQ) of 69 assessed by the Wechsler Preschool
and Primary Scale. Growth parameters were as follows:
weight 14 kg (3rd centile), height 103 cm (10-25th centile),
and OFC 48 cm (<3rd centile). At this stage, SLOS was
suspected, and the molecular analysis of the DHCR7
revealed the presence of two mutations: c.521 T > C
(p.Phe174Ser), inherited from the mother and c.724C > T
(p.Arg242Cys), inherited from the father, confirming the
diagnosis.
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Fig. 1 The patient's facial appearance (a, b) and the foot showing
the 2,3 toe syndactyly (c), and the hands (d, e)
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With this report, we described a patient with a mild
form of SLOS, who presented with subtle structural
anomalies of the genitourinary tract associated with mild
dysmorphic features and mild ID. The patient presented
in this study demonstrated some of the typical SLOS facial
dysmorphisms, microcephaly and growth failure. Despite
being typical, these features are non-specific and are also
present in other syndromic genetic conditions . Indeed, he
was tested in the first place for Noonan syndrome, which
was not confirmed. By and large, there were no clinical
features that are pathognomonic for SLOS. Moreover, es-
tablishing a diagnosis can be complicated by the broad
and variable phenotypic spectrum. The case here pre-
sented with bilateral syndactyly of the second and third
toe, confirming the importance of this feature in establish-
ing the diagnosis of SLOS. The patient was found to have
bilateral ectasia of the pelvis and bifid pelvis on one side.
Genitourinary malformations generally present in the
most severe forms of the disorder with kidney agenesis,
hypoplasia, ectopia [12] or with ambiguous genitalia, espe-
cially female-appearing genitalia or severe hypospadia
[13]. Our case presented with an isolated dilatation of the
pelvis,, highlighting the importance of subtle anomalies of
the genitourinary tract in guiding diagnosis in the mild
forms of SLOS.
Our case had two mutations in the DHCR7 gene:
p.Arg242Cys and p.Phe174Ser. Whilst the p.Arg242Cys
mutation has been repeatedly reported in patients affected
by SLOS [14, 15], the p.Phe174Ser has only been reported
in one Portuguese patient [11]. The evidence of pathogen-
icity of this mutation is restricted to this report only, mak-
ing it difficult to interpret this variant in a clinical setting.
With this report, we provided further evidence of patho-
genicity of this variant: (1) we describe this variant in asso-
ciation with another known pathogenic variant in a
patient with SLOS; (2) the affected residue is phylogenet-
ically highly conserved in human, dog, mouse, and rhesus
monkey; (3) the Grantham difference is 154.81 and (4) the
affected residue does not tolerate the phenylalanine to
serine missense mutation according to in silico prediction
programs such as SNP&GO, Polyphen, SIFT, PANTHER,
Mutation Assessor and Mutation t@sting (Fig. 2).
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Fig. 2 a Chromatograms showing the c.521 T > C (p.Phe174Ser), and the c.724C > T (p.Arg242Cys) mutations. b In silico programs showing
the predicted effect of the p.Phe174Ser mutation on the DHCR7. SNP&GO, http://snps-and-go.biocomp.unibo.it/snps-and-go/; Polyphen,
http://genetics.bwh.harvard.edu/pph2/; SIFT, http://sift.jcvi.org/; PANTHER, http://www.pantherdb.org/tools/csnpScoreForm.jsp; Mutation
Assessor, http://mutationassessor.org/; Mutation t@sting, http://www.mutationtaster.org/ c Amino acid conservation between different
species at the position 174 of the DHCR7
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Although genotype–phenotype correlation for SLOS is
complicated by the broad mutational spectrum found in
this disorder, most patients with very mild clinical and
biochemical phenotypes are compound heterozygotes
for two unique or uncommon missense mutations [13].
Recent studies suggested that those with one or two mu-
tations in loop 1–2 or one mutation in the N-terminus
usually have milder phenotypes, while the most severe
phenotypes are observed in individuals with two null
mutations or with two mutations in loop 8–9. The
p.Phe174Ser and the p.Arg242Cys mutations are in the
TM3 and TM5 domains, respectively. A patient who
was compound heterozygous for two mutations in loop
3–4 of the TM5 domain has been previously reported
with a mild form of SLOS [15], confirming the observa-
tion that carrying two mutations located near these do-
mains causes a less severe phenotype. The patient
presented in this study and the previously reported Por-
tuguese patient carrying the p.Phe174Ser mutation are
both affected by a form of SLOS on the mild end of the
spectrum. Table 1 summarizes the differences between
our case and the one with the p.Phe174Ser mutation
that was previously reported. On the basis of these ob-
servations, it is possible to assume that the p.Phe174Ser
variant is associated with mild forms of SLOS.
Conclusions
We report a patient with a mild case of SLOS who pre-
sented with microcephaly, mild ID, and isolated pelvis
ectasia. This highlights the importance of recognizing sub-
tle anomalies of the genitourinary system associated with
mild dysmorphic features and mild ID in establishing the
diagnosis of mild forms of SLOS. This study offers further
clinical significance to the p.Phe174Ser variant and pro-
vides evidence for its association with mild forms of SLOS.
This finding further establishes a genotype–phenotype
correlation for SLOS, which will facilitate counselling for
this disorder and the prediction of therapeutic responses.
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